NovaBridge Biosciences (NBP) Work In Process (2020 - 2021)
NovaBridge Biosciences (NBP) reported Work In Process of $39.7 million for Q4 2021, up 15.69% year-over-year from $34.3 million in Q4 2020, and up 15.69% quarter-over-quarter from $34.3 million in Q4 2020.
NovaBridge Biosciences (NBP) Work In Process (2020 - 2021) Analysis & Trends
NovaBridge Biosciences (NBP) has 2 years of Work In Process data on file, last reported at $39.7 million in Q4 2021.
- Work In Process for Q4 2021 came in at $39.7 million, up 15.69% year-over-year; the trailing twelve-month figure through Dec 2021 was $39.7 million (up 15.69% YoY), and the FY2021 annual result was $39.8 million, up 14.28% from the prior year.
- Work In Process improved to $39.7 million in Q4 2021 per NBP's latest filing, from $34.3 million in the prior quarter.
- Over five years, Work In Process peaked at $39.7 million in Q4 2021 and troughed at $34.3 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | NovaBridge Biosciences | 328.19 Mn | 117.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 39.69 Mn |
| Dec 31, 2020 | 34.31 Mn |